AbbottAbbott
INT

MitraClipTM TMVr

The Leader in
Transcatheter Mitral
Valve Repair Technology

Breakthrough TMVr Therapy for SELECT PATIENTS WITH MITRAL REGURGITATION

MitraClip is the world’s first transcatheter mitral valve repair (TMVr) therapy that delivers a treatment option for patients with mitral regurgitation who would otherwise go untreated.1,2

Over 100,000 patients worldwide* have been treated with MitraClip™ therapy, with over 30,000 patients* followed through multiple studies and registries.

*Data on file at Abbott.

Minimally Invasive Procedure

The MitraClip™ TMVr procedure is a minimally invasive catheter-based therapy performed by multidisciplinary Heart Teams.1 Open-heart surgery to repair or replace the mitral valve is generally recommended, but it is not an option for many patients.

TMVr with MitraClip therapy delivers a treatment option for patients who are not good surgical candidates.1,2

MitraClip procedure video
  • Corrado Tamburino discusses MitraClip therapy
  • CORRADO TAMBURINO
    Interventional Cardiologist/Cardiologist, University of Catania, Italy

    “We can tailor the therapy patient by patient, giving a very low risk (MitraClip) therapy with a high benefit result.”†

MAT-2010221 v1.0 | Item approved for Global OUS use only.

References

† The testimonial does not provide any indication, guide, warranty or guarantee as to the response patients may have to the treatment or effectiveness of the product or therapy in discussion. Opinions about the treatment discussed can and do vary and are specific to the individual’s experience and might not be representative of others.

  1. MitraClip G4 Clip Delivery System Instructions for Use.
  2. Lim DS, Reynolds MR, Feldman T, et al. Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after the transcatheter mitral valve repair. J Am Coll Cardiol. 2014;64(2):182-192.

GET CLINICAL INSIGHTS

DOWNLOAD

PATIENT EDUCATION

READ MORE

Let’s get in touch!

Contact us

Copyright © 2021 Abbott. Abbott Park, Illinois, U.S.A.
Caution: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or at eifu.abbottvascular.com or at medical.abbott/manuals for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.
Illustrations are artist's representations only and should not be considered as engineering drawings or photographs. Photos on file at Abbott.
Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

MAT-2000631 v5.0 | Item approved for Global OUS use only.

Sign up

Receive updates from Abbott Structural Heart

Register now

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of the product that are not approved in other countries or regions.

International Health Care Professionals U.S. Health Care Professionals

YOU ARE ABOUT TO LEAVE
www.structural­heart­solutions.com

You are now leaving www.structuralheartsolutions.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

OkCancel